Susquehanna International Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $564M | Sell |
20,095,000
-10,611,700
| -35% | -$283M | 0.06% | 239 |
|
|
2025
Q4 | $765M | Sell |
30,706,700
-1,676,700
| -5% | -$42.3M | 0.09% | 174 |
|
|
2025
Q3 | $825M | Sell |
32,383,400
-6,102,100
| -16% | -$151M | 0.09% | 161 |
|
|
2025
Q2 | $933M | Buy |
38,485,500
+3,268,900
| +9% | +$76.2M | 0.13% | 121 |
|
|
2025
Q1 | $892M | Buy |
35,216,600
+6,237,700
| +22% | +$163M | 0.15% | 104 |
|
|
2024
Q4 | $769M | Buy |
28,978,900
+802,400
| +3% | +$21.8M | 0.12% | 124 |
|
|
2024
Q3 | $815M | Buy |
28,176,500
+1,543,800
| +6% | +$45M | 0.14% | 115 |
|
|
2024
Q2 | $745M | Sell |
26,632,700
-3,283,500
| -11% | -$90.4M | 0.14% | 110 |
|
|
2024
Q1 | $830M | Buy |
29,916,200
+1,833,100
| +7% | +$50.9M | 0.14% | 113 |
|
|
2023
Q4 | $809M | Buy |
28,083,100
+17,232,200
| +159% | +$521M | 0.15% | 89 |
|
|
2023
Q3 | $360M | Buy |
10,850,900
+479,400
| +5% | +$17M | 0.07% | 206 |
|
|
2023
Q2 | $380M | Sell |
10,371,500
-432,700
| -4% | -$16.8M | 0.08% | 190 |
|
|
2023
Q1 | $441M | Buy |
10,804,200
+2,725,500
| +34% | +$118M | 0.09% | 165 |
|
|
2022
Q4 | $414M | Sell |
8,078,700
-858,400
| -10% | -$41.2M | 0.1% | 158 |
|
|
2022
Q3 | $391M | Sell |
8,937,100
-495,100
| -5% | -$24.1M | 0.1% | 155 |
|
|
2022
Q2 | $495M | Sell |
9,432,200
-1,187,000
| -11% | -$60.5M | 0.12% | 116 |
|
|
2022
Q1 | $550M | Sell |
10,619,200
-5,124,700
| -33% | -$266M | 0.1% | 149 |
|
|
2021
Q4 | $930M | Sell |
15,743,900
-2,820,000
| -15% | -$140M | 0.14% | 96 |
|
|
2021
Q3 | $798M | Buy |
18,563,900
+2,591,400
| +16% | +$115M | 0.11% | 133 |
|
|
2021
Q2 | $625M | Sell |
15,972,500
-32,800
| -0.2% | -$1.28M | 0.09% | 183 |
|
|
2021
Q1 | $580M | Sell |
16,005,300
-5,005,800
| -24% | -$178M | 0.09% | 176 |
|
|
2020
Q4 | $773M | Buy |
21,011,100
+6,594,383
| +46% | +$242M | 0.13% | 111 |
|
|
2020
Q3 | $502M | Buy |
14,416,717
+1,137,476
| +9% | +$39.9M | 0.1% | 150 |
|
|
2020
Q2 | $412M | Buy |
13,279,241
+2,764,221
| +26% | +$93.9M | 0.1% | 163 |
|
|
2020
Q1 | $326M | Buy |
10,515,020
+3,894,214
| +59% | +$133M | 0.1% | 158 |
|
|
2019
Q4 | $246M | Sell |
6,620,806
-554,088
| -8% | -$19.7M | 0.07% | 226 |
|
|
2019
Q3 | $245M | Buy |
7,174,894
+3,306,082
| +85% | +$120M | 0.08% | 206 |
|
|
2019
Q2 | $159M | Buy |
3,868,812
+1,313,705
| +51% | +$52.2M | 0.06% | 280 |
|
|
2019
Q1 | $103M | Sell |
2,555,107
-162,843
| -6% | -$6.52M | 0.04% | 363 |
|
|
2018
Q4 | $113M | Sell |
2,717,950
-70,407
| -3% | -$2.92M | 0.04% | 345 |
|
|
2018
Q3 | $117M | Sell |
2,788,357
-569,687
| -17% | -$21.9M | 0.04% | 397 |
|
|
2018
Q2 | $116M | Sell |
3,358,044
-449,742
| -12% | -$15.4M | 0.04% | 374 |
|
|
2018
Q1 | $128M | Sell |
3,807,786
-2,022,520
| -35% | -$69.5M | 0.05% | 318 |
|
|
2017
Q4 | $200M | Sell |
5,830,306
-773,215
| -12% | -$26.4M | 0.07% | 240 |
|
|
2017
Q3 | $224M | Sell |
6,603,521
-116,572
| -2% | -$3.75M | 0.09% | 195 |
|
|
2017
Q2 | $214M | Sell |
6,720,093
-2,324,492
| -26% | -$73.3M | 0.09% | 178 |
|
|
2017
Q1 | $294M | Sell |
9,044,585
-1,233,812
| -12% | -$38.9M | 0.15% | 106 |
|
|
2016
Q4 | $317M | Buy |
10,278,397
+87,166
| +0.9% | +$2.66M | 0.16% | 103 |
|
|
2016
Q3 | $327M | Buy |
10,191,231
+2,069,002
| +25% | +$69.2M | 0.16% | 95 |
|
|
2016
Q2 | $271M | Sell |
8,122,229
-4,878,650
| -38% | -$156M | 0.15% | 112 |
|
|
2016
Q1 | $366M | Sell |
13,000,879
-2,492,499
| -16% | -$71.2M | 0.19% | 77 |
|
|
2015
Q4 | $475M | Buy |
15,493,378
+5,148,263
| +50% | +$162M | 0.22% | 70 |
|
|
2015
Q3 | $308M | Buy |
10,345,115
+4,117,240
| +66% | +$132M | 0.13% | 120 |
|
|
2015
Q2 | $198M | Sell |
6,227,875
-11,700
| -0.2% | -$381K | 0.08% | 196 |
|
|
2015
Q1 | $206M | Sell |
6,239,575
-3,034,993
| -33% | -$96.5M | 0.09% | 191 |
|
|
2014
Q4 | $274M | Sell |
9,274,568
-1,894,881
| -17% | -$54.3M | 0.11% | 166 |
|
|
2014
Q3 | $313M | Buy |
11,169,449
+566,841
| +5% | +$15.9M | 0.12% | 126 |
|
|
2014
Q2 | $299M | Buy |
10,602,608
+3,456,699
| +48% | +$98.5M | 0.13% | 111 |
|
|
2014
Q1 | $218M | Buy |
7,145,909
+1,066,859
| +18% | +$31.8M | 0.1% | 166 |
|
|
2013
Q4 | $177M | Sell |
6,079,050
-1,603,556
| -21% | -$46.7M | 0.08% | 193 |
|
|
2013
Q3 | $209M | Sell |
7,682,606
-6,165,268
| -45% | -$168M | 0.11% | 137 |
|
|
2013
Q2 | $368M | Buy |
+13,847,874
| New | +$383M | 0.21% | 62 |
|
Other funds holding PFE
VCM
VPM
Susquehanna International Group's PFE Position: Q1 2026 in Review
Susquehanna International Group reduced its Pfizer (PFE) stake by 68% in Q1 2026, selling an estimated $68.5M and leaving 1,186,035 shares worth $33.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.
Susquehanna International Group first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $965M in Q2 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Susquehanna International Group held 1,186,035 shares of Pfizer worth $33.3M as of Q1 2026.
- Susquehanna International Group sold 2,572,047 Pfizer shares in Q1 2026, an estimated $68.5M.
- Pfizer made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1632 holding.
- Susquehanna International Group first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Susquehanna International Group's Pfizer position peaked at $965M in Q2 2013.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.